Abstract

A mini volume loading test (mVLT) method is used for decision making in our prototype semi-closed loop infusion system (SCLIS). The mVLT fluid protocol consists of hemodilution response-guided mini fluid challenges. Each mini fluid challenge (MFC) consists of a 2.5 ml kg -1 –5 ml kg -1 crystalloid bolus infused over 2 min–5 min and followed by a 5 min period with no fluids. Arterial plasma dilution efficacy (aPDE) of a MFC is calculated from invasively measured hemoglobin (aHb) before and after each MFC. Capillary plasma dilution efficacy ( cPDE ) is calculated from non-invasively measured hemoglobin (SpHb). The zero or negative arterio-capillary plasmadilution efficacy difference ( acPED ≤ 0 p.d.u.) is an indication of hemodilution non-response and imminent edema . However, it requires both invasive and non-invasive hemoglobin measurements. A non-invasive assessment of hemodilution response within the mVLT method would increase its practical application and reduce costs further enhancing its applicability in the SCLIS. This possibility exists if the cPDE could reliably predict the acPED value or the hemodilution response (the presence of acPED within a range of > 0) or non-response ( acPED ≤ 0). We report a retrospective observational study in an elective total knee arthoplasty (TKA) setting. The 2.5 ml kg -1 boluses were used in six MFCs in both pre- and post-operative mVLT sessions. The primary objective was to assess the accuracy of cPDE in predicting the hemodilution response using the receiver operating characteristic (ROC) curve and gray zone approaches. Our secondary objective was to investigate the feasibility of a statistical optimization method (SOM) in predicting the acPED . The analysis included 480 paired values of cPDE and acPED . The best cut-off value for cPDE was 0.015 p.d.u. (specificity = 0.84, sensitivity = 0.90). The gray zone identified a range of cPDE values between 0.013 and 0.028 (p.d.u.) for which the hemodilution response could not be indicated reliably. The 14 % of the cPDE values were in this range. The non-invasive evaluation of hemodilution response is acceptably accurate in the perioperative TKA setting. The mVLT algorithm within our prototype SCLIS was upgraded by implementing the results of the present study. DOI: http://dx.doi.org/10.5755/j01.eee.22.1.12826

Highlights

  • A mini volume loading test is used for decision making in a semi-closed loop infusion system (SCLIS) [1]– [5]

  • The stepwise infusion was administered according to a revised goal directed therapy protocol consisting of conventional GDT supplemented by the mini volume loading test (mVLT) [2]

  • The variables were recorded during five mini fluid challenges in each of the 48 pre- and 48 post-operative mVLT sessions

Read more

Summary

INTRODUCTION

A mini volume loading test (mVLT) is used for decision making in a semi-closed loop infusion system (SCLIS) [1]– [5]. The mVLT fluid protocol implies hemodilution guided mini fluid challenges. These are 2.5 ml kg-1–5 ml kg-1 boluses infused over 2 min–5 min, each followed by a 5 min period with no fluids. The assessment of hemodilution response requires hemoglobin measures before and after each mini fluid challenge (MFC). Based on observations in healthy volunteers [1] and patients [2], a transcapillary reflux model suggests that acPED ≤ 0 p.d.u. is an indication hemodilution nonresponse and imminent edema. This signifies that fluid loading should be stopped. The secondary objective was to investigate the feasibility of a statistical optimization method (SOM) in predicting the acPED using the measured cPDE

MATERIALS AND METHODS
Sample Size
Threshold and Gray Zone Determination
RESULTS
The ROC Curve and Gray Zone Approaches
Actual Hemodilution Response
SOM Predicted Hemodilution Response
DISCUSSION
CLINICAL IMPLICATIONS
CONFLICT OF INTERESTS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.